Jeevan Jyot

Jeevan Jyot,

Research Coordinator III

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-7720
Business Email: jyotj@ufl.edu

Publications

2021
High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients.
PloS one. 16(6) [DOI] 10.1371/journal.pone.0253259. [PMID] 34115807.
2015
A Detailed Characterization of the Dysfunctional Immunity and Abnormal Myelopoiesis Induced by Severe Shock and Trauma in the Aged.
Journal of immunology (Baltimore, Md. : 1950). 195(5):2396-407 [DOI] 10.4049/jimmunol.1500984. [PMID] 26246141.
2013
Exchangeability of the flagellin (FliC) and the cap protein (FliD) among different species in flagellar assembly.
Biopolymers. 99(1):63-72 [DOI] 10.1002/bip.22141. [PMID] 23097231.
2013
Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa.
Infection and immunity. 81(6):2043-52 [DOI] 10.1128/IAI.00054-13. [PMID] 23529619.
2013
Transcriptional response of mucoid Pseudomonas aeruginosa to human respiratory mucus.
mBio. 3(6):e00410-12 [DOI] 10.1128/mBio.00410-12. [PMID] 23143799.
2011
Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection.
The Journal of infectious diseases. 203(10):1369-77 [DOI] 10.1093/infdis/jir045. [PMID] 21502078.
2010
Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway.
PloS one. 5(2) [DOI] 10.1371/journal.pone.0009351. [PMID] 20195469.
2008
Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.
Journal of immunology (Baltimore, Md. : 1950). 181(1):586-92 [PMID] 18566425.
2007
Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus.
Molecular microbiology. 63(4):1026-38 [PMID] 17238927.
2006
Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa.
Infection and immunity. 74(12):6682-9 [PMID] 16982831.
2006
Pseudomonas aeruginosa LecB is involved in pilus biogenesis and protease IV activity but not in adhesion to respiratory mucins.
Infection and immunity. 74(12):7035-9 [PMID] 17015462.
2004
Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients.
Proceedings of the National Academy of Sciences of the United States of America. 101(17):6664-8 [PMID] 15084751.
2003
A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa.
Molecular microbiology. 50(3):809-24 [PMID] 14617143.
2002
FleQ, the major flagellar gene regulator in Pseudomonas aeruginosa, binds to enhancer sites located either upstream or atypically downstream of the RpoN binding site.
Journal of bacteriology. 184(19):5251-60 [PMID] 12218010.
2002
Identification and functional characterization of flgM, a gene encoding the anti-sigma 28 factor in Pseudomonas aeruginosa.
Journal of bacteriology. 184(6):1514-21 [PMID] 11872701.
2001
Evaluation of inoculum addition to stimulate in situ bioremediation of oily-sludge-contaminated soil.
Applied and environmental microbiology. 67(4):1675-81 [PMID] 11282620.
2001
In situ bioremediation potential of an oily sludge-degrading bacterial consortium.
Current microbiology. 43(5):328-35 [PMID] 11688796.
1999
Localization of DnaK and GroEL in Vibrio cholerae.
FEMS microbiology letters. 172(2):165-71 [PMID] 10188245.
1998
Heterogeneity in the organization of the CTX genetic element in strains of Vibrio cholerae O139 Bengal isolated from Calcutta, India and Dhaka, Bangladesh and its possible link to the dissimilar incidence of O139 cholera in the two locales.
Microbial pathogenesis. 24(3):175-83 [PMID] 9514639.

Contact Details

Phones:
Business:
(352) 273-7720
Emails:
Business:
jyotj@ufl.edu
Addresses:
Business Mailing:
PO Box 115500
GAINESVILLE FL 32611
Business Street:
Dept. of Pharmaceutical Outcomes & Policy
College of Pharmacy, University of Florida
1225 Center Dr, HPNP 2321
GAINESVILLE FL 32611